PTAB challenges

Proceedings overview

One Inter Partes Review (IPR) proceeding has been filed against US Patent 11589969. This proceeding resulted in a discretionary denial of institution, meaning no claims were invalidated. This gives a defendant a stronger defensive posture, as the patent owner successfully defended against an IPR challenge at the institution stage.

IPR2025-01020 — Ascentcare Dental Products, Inc. v. Solmetex, LLC

• Type: Inter Partes Review
• Filed: 2025-05-20
• Status: Discretionary Denial. The petition was not instituted for trial.
• Judge panel: Administrative Judge Coke Morgan Stewart is associated with the case. However, according to USPTO policy effective from October 17, 2025, institution determinations in IPR and PGR cases, covering both discretionary and merits considerations, are personally made by the Director, with routine decisions issued as summary notices.
• Petition grounds: Ascentcare Dental Products, Inc. (Petitioner) challenged claims of US Patent 11589969, arguing for their unpatentability. The petition included arguments concerning the claim term "wave shape" in the independent claims, with the Petitioner asserting that prior art, such as Black and Baughan, teaches "square waves," which would render the claims invalid. These arguments typically fall under 35 U.S.C. §§ 102 (anticipation) or 103 (obviousness).
• Institution decision: Denied on 2025-10-10. The denial was discretionary, indicated by the status "Discretionary Denial" and the "Not Instituted - Procedural" note on the Google Patents page for US11589969. This means the decision was based on factors other than the merits of the prior art arguments, such as the Fintiv factors (involving parallel district court litigation) or the "settled expectations" doctrine, which considers how long a patent has been issued and unchallenged. The specific reasoning for this particular discretionary denial is not explicitly detailed in the publicly available snippets beyond these general policy contexts.
• Final Written Decision: Not issued, as the petition for institution was denied.
• Settlement / termination: The proceeding was terminated on 2025-10-10 following the denial of institution. There is no indication of a settlement.
• Appeal: No appeal to the Federal Circuit was possible, as no Final Written Decision was issued.
• Defensive value: The patent owner prevailed at the institution stage. This means that Ascentcare Dental Products, Inc. (and potentially their privies) is estopped under 35 U.S.C. § 315(e)(1) from challenging claims of US11589969 in district court or the ITC on any ground that was raised or reasonably could have been raised in this IPR. For other potential defendants, this indicates that the patent survived a PTAB challenge, and an IPR-based defense targeting the same grounds of unpatentability will be more challenging.

Strategic summary

All claims of US Patent 11589969 remain SUSTAINED as no claims were invalidated. The single IPR filed against the patent, IPR2025-01020, resulted in a discretionary denial of institution, meaning the merits of the unpatentability challenge were not decided by the PTAB. Consequently, all claims of the patent are considered untested on their merits at the PTAB.

The estoppel landscape is primarily relevant for Ascentcare Dental Products, Inc. and its privies. Under 35 U.S.C. § 315(e)(1), they are barred from asserting in any other forum any ground of unpatentability that they raised or reasonably could have raised during IPR2025-01020. For other potential defendants, the grounds raised by Ascentcare Dental Products, Inc. (e.g., anticipation or obviousness based on prior art like Black and Baughan concerning the "wave shape" feature) are technically still available for challenge in a new IPR or district court litigation, as they were not adjudicated on the merits. However, the discretionary denial itself may signal a higher bar for institution for similar petitions against this patent, especially if the denial was based on factors like parallel litigation (Fintiv) or the timing of the petition (settled expectations).

There are no apparent pattern signals such as multiple IPRs filed by the same petitioner or aggressive PTAB appeals by the patent owner, given only one IPR has concluded with a denial of institution. Unified Patents is listed as a source for PTAB data related to this case, indicating their monitoring of the patent landscape.

Recommended next steps

For a defendant facing assertion of US11589969, it is important to understand the specific basis for the discretionary denial in IPR2025-01020. While the full reasoning for the discretionary denial is not explicitly detailed in the provided snippets, it likely pertains to factors such as parallel district court litigation (as Solmetex has asserted the '969 patent against Ascentcare in a related matter in the Western District of Michigan) or the USPTO's "settled expectations" policy.

Defendants should carefully review the public records of IPR2025-01020 available on the USPTO PTAB E2E system to understand the precise grounds raised by Ascentcare Dental Products, Inc. and the specific reasoning for the discretionary denial. This will inform whether a new IPR challenge on different grounds, or even the same grounds if new prior art or legal arguments can be presented, might be more successful. The fact that the patent owner prevailed at institution means any new IPR would need to overcome the initial discretionary hurdles set by the PTAB, which have become more stringent recently.